What AnteAGE does

AnteAGE, operating as a division of Cellese (a privately held biotech company), is a growth factor and exosome-based skincare company headquartered in Irvine, California. The company develops and commercializes skincare products built on proprietary Cytosignal cell technology, which uses recombinant growth factors and biomimetic exosomes (Biosomes) cultured in laboratory-controlled environments. Its product portfolio spans three tiers: (1) AnteAGE MD, exclusively physician-dispensed products for medical aesthetic practices, dermatologists, and plastic surgeons including Serum, Accelerator, MDX Biosome Solution, Growth Factor Solutions for skin and hair, and Biogel; (2) AnteAGE Professional, topical solutions for estheticians offering microneedling and facial treatments; and (3) AnteAGE Home Care, direct-to-consumer products including Eye Reset, Barrier Repair with Biosomes, and home microneedling systems. Core technical differentiators include hybrid source exosome technology, lyophilized preservation for potency, and 100% cell-free, cruelty-free, paraben-free, and pathogen-free formulations.

The company operates a multi-channel distribution model combining enterprise field sales to authorized medical providers (with required dispensing physician oversight), channel partner distribution through a vetted authorized provider network spanning 35+ countries, and direct-to-consumer e-commerce through anteage.com. Regional entities (AnteAGE Europe and AnteAGE Middle East) support international operations in the UK, Ireland, and UAE. Pricing for premium SKUs ranges from $110 to $324, positioning the brand in the medical-grade skincare segment. Named customers include Cleveland Clinic, Vancouver Laser, Tribeca Medspa, SkinPerfect, and Epicentre.

The business has executed a sustained product launch cadence from 2020 through 2026, including geographic expansion into the UK (2020-2022), women's health aesthetics (Vaginal Rejuvenation Solution, 2022), hair regeneration (Home Hair System, 2022), consumer eye care (Eye Reset, 2023), and the P.E.A.R.L. multi-targeted system combining exosomes and PDRN (2025). The company is privately held with no disclosed external funding rounds, operating within the Cellese parent structure.

Name

AnteAGE

Legal name

Cellese

Website

https://anteage.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

AnteAGE, a division of biotech company Cellese, develops and sells growth factor and exosome-based skincare products across physician-dispensed, professional esthetician, and direct-to-consumer channels, serving medical aesthetic practices, dermatologists, and home care consumers globally.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Skincare

NAICS

Toilet Preparation Manufacturing (32562), Toilet Preparation Manufacturing (325620)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)

akta.pro secondary industries

Professional Skincare & Facial Treatments (CRABALAF), Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE)

Keywords

• Growth factor skincare
• Exosome aesthetics
• Professional skincare systems
• Physician-dispensed skincare
• Regenerative anti-aging

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Professional Product Sales: Sale of AnteAGE MD treatment solutions and professional skincare products exclusively to physicians, med spas, and licensed aesthetic practitioners. Products include Serum, Accelerator, Growth Factor Solution, Hair Growth Factor Solution, Biogel, and MDX Biosome System.
2. Consumer Home Care Sales: Direct-to-consumer sales of home skincare products through anteage.com and authorized provider e-commerce portals. Includes Serum, Accelerator, Eye Reset, Barrier Repair, and at-home treatment solutions.
3. Professional Skincare Line: Sale of AnteAGE Professional line products to estheticians and skincare professionals for microneedling and facial treatments.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

AnteAGE manufactures and sells recombinant growth factor and biomimetic exosome (Biosome) skincare products through a multi-tiered channel. Its portfolio includes physician-dispensed AnteAGE MD treatment solutions for in-office aesthetic procedures, AnteAGE Professional systems for estheticians performing microneedling and facials, and AnteAGE Home Care products sold directly to consumers for daily anti-aging skincare and hair regeneration.

Product overview

AnteAGE is a growth factor skincare company offering a multi-tiered product portfolio spanning professional in-office treatments, physician-dispensed medical skincare, and consumer home care. The core product lines include: (1) AnteAGE MD System - a two-step Serum and Accelerator daily skincare system with recombinant growth factors; (2) AnteAGE MDX Biosome Solution - a lyophilized biomimetic exosome product for in-office procedures; (3) Professional treatment products including Growth Factor Solutions and Biogel for microneedling, laser, and other aesthetic treatments; (4) Targeted treatments like Eye Reset and Barrier Repair with Biosomes; and (5) Hair regeneration solutions. The company also offers the P.E.A.R.L. system combining Exosomes and PDRN. Products are cruelty-free, cell-free, paraben-free, and pathogen-free, utilizing Cytosignal technology with recombinant growth factors and cytokines derived from stem cell research.

Differentiator

Problem solved

Functional benefit

Brands

• P.E.A.R.L. Complete Multi-Targeted System combining Exosomes and PDRN for in-office aesthetic treatments
• Biosomes
• AnteAGE MDX

Products and services

• AnteAGE MD Biosome System

Quantifiable outcome

• Improved skin firmness, reduced redness, decreased signs of aging, improved skin texture and tone

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Revision Skincare: Professional-channel skincare brand with physician-dispensed lines focused on anti-aging and post-procedure care. Comparable on professional-only distribution and treatment-oriented product positioning.
• iS Clinical: Professional skincare line sold through spas, physicians, and licensed professionals with a focus on treatment-oriented serums. Comparable in professional-channel GTM and clinical positioning for aesthetic practices.
• Alastin Skincare: Galderma-owned physician-dispensed skincare line built around TriHex Technology for procedure support and anti-aging. Closely comparable on channel (authorized providers), regenerative science positioning, and post-procedure use cases.
• EltaMD: Physician-dispensed skincare brand with strong presence in dermatology offices and med spas. Comparable in physician-channel distribution and medical-grade skincare positioning, particularly around post-procedure care.
• ZO Skin Health: Zein Obagi-founded brand exclusively sold through physicians and medically directed spas. Comparable in physician-dispensed, results-oriented anti-aging positioning and provider-network go-to-market.
• SkinMedica: Physician-dispensed skincare brand owned by Allergan/AbbVie, known for growth factor-based products (e.g., TNS) sold through dermatologists and med spas. Directly comparable in channel strategy, professional positioning, and growth factor science.
• Neocutis: Physician-dispensed skincare brand originally built on PSP (Processed Skin Cell Proteins) growth factor technology. Direct competitor in growth factor skincare sold through dermatologists and plastic surgeons.

Broad incumbents

• SkinCeuticals: L'Oréal-owned professional skincare brand with deep penetration in dermatology and med-spa channels. Comparable in professional skincare positioning, though it operates as part of a much larger portfolio with broader retail and physician reach.
• Dermalogica: Global professional skincare brand sold through skin therapists and licensed estheticians. Comparable in professional-channel distribution and treatment-oriented anti-aging positioning, though it is a broader portfolio player.

Emerging players

• Plated Skin Science: Direct-to-consumer exosome-based skincare brand using platelet-derived growth factor technology. Comparable in exosome/growth factor science, though primarily DTC rather than physician-dispensed.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/celleseanteage
• Facebookfacebook.com/anteage
• LinkedInlinkedin.com/company/anteage

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AnteAGE